Attention:
Card image cap

How Will Law Treat Science and Medicine Once the Pandemic Subsides?


Level: Advanced
Runtime: 93 minutes
Recorded Date: May 13, 2020
Click here to share this program
Printer-Friendly Version
Closed Caption

Agenda

  • Gain a deeper perspective, from a panel that includes two PhDs, of the current legal, regulatory, bioethics and policy issues confronting the “first responders” from the international life sciences, health care and scientific community in dealing with the consequences of the COVID-19 pandemic.
  • Learn how decisive action during this global emergency is challenged by a patchwork of statutes, regulations, ethical considerations and conflicting expressions of public policy--and some suggestions for short and long-term solutions;
  • Obtain a fuller understanding of the legal and ethical issues in dealing with shortages of critical medical products, some conflicting approaches by government and the public’s perception of these sectors;
  • Learn how life sciences and healthcare organizations may fare in the courts and regulatory agencies once the pandemic is over and a vaccine is available.

Runtime: 1 hour, 33 minutes
Recorded May 13, 2020

For NY - Difficulty Level: Experienced attorneys only (non-transitional)

Description

In this program, a panel of distinguished experts will provide an overview and pragmatic discussion of selected key practical and legal hurdles and traps that health care providers and life sciences companies must overcome in pursuing their mission.

This program was recorded on May 13th, 2020.

Provided By

American Bar Association
Card image cap

Panelists

Card image cap

Paul R. DeMuro

Retired Partner
Latham & Watkins LLP

Paul DeMuro retired from Partnership on September 30, 2012. Also a CPA, his practice focused on corporate, healthcare law and technology. Mr. DeMuro is currently pursuing his PhD in Biomedical Informatics at Oregon Health and Science University School of Medicine.

Mr. DeMuro is a member of the American Institute of Certified Public Accountants, the American Medical Informatics Association, the Medical Group Management Association, and a Fellow in The American College of Medical Practice Executives, the Healthcare Financial Management Association, the Health Care Compliance Association, the American College of Healthcare Executives and the American Health Lawyers Association. Chambers USA has listed Mr. DeMuro as a leading California Healthcare lawyer from 2007 to 2011.

Mr. DeMuro has authored more than 100 publications on various topics, such as: accountable care organizations, biomedical informatics, clinical integration, mergers and acquisitions, capital finance, corporate governance, Medicare reimbursement, fraud and abuse and various healthcare issues.

Card image cap

James Burgess

CEO
American Biomedical Group, Inc.

James Burgess is the CEO of The American Biomedical Group.

Card image cap

Gerald P. Schneeweis

Member
Clark Hill PLC

For over 35 years, Gerald Schneeweis has represented clients in state and federal trial and appellate courts. These include pharmaceutical, medical device, and other manufacturers in product liability litigation asserting claims of design and manufacturing defect, failure to warn and off-label promotion. He has acted as coordinating, regio­nal and local counsel in federal and state-wide coordinated proceedings, asserting product liability claims against life sciences manufacturers and research entities. He served as lead coordinating counsel in multi-plaintiff product liability litigation on behalf of a dermal filler manufacturer/clinical trial sponsor and several of its former executives, officers and directors. He has also counseled manufacturers and insurers on various product liability issues, including adequacy of warnings, marketing, and FDA rules on promotion of off-label use.

In addition, Gerry has represented industrial, consumer and agricultural research companies in product liability, breach of warranty and breach of contract litigation. His experience also includes the representation of clients in design and engineering firms and retailers in commercial disputes, unfair competition and business torts, as well as IP litigation.

He is a member of the American Bar Association, Defense Research Institute and the American Board of Trial Advocates.

Card image cap

Cynthia M. Stamer

Attorney
Cynthia Marcotte Stamer PC

A nationally recognized workforce and health care management attorney, strategist, author, and advocate, Cynthia Marcotte Stamer is Martindale-Hubble AV-Preeminent (highest/top 1%) attorney Board Certified in Labor & Employment Law by Texas Board of Legal Specialization and American College of Employee Benefit Counsel Fellow, recognized as a "Top Woman Lawyer," "Top Rated Lawyer,” and "LEGAL LEADER™" in Health Care Law and Labor and Employment Law; among the “Best Lawyers In Dallas” in “Labor & Employment,” “Tax: ERISA & Employee Benefits,” “Health Care” and “Business and Commercial Law, and with numerous other accolades for deploying her extensive legal and business knowledge with an insightful and pragmatic solutions orientation to provide client centric performance, compliance, risk, crisis and change management, health and employee benefit design and innovation, public policy and regulatory affairs advice, representation and advocacy, litigation and other enforcement defense representation, strategy, consulting counsel and expert witness services other operations critical legal and operations management advice, representation, coaching and training, regulatory affairs and other advocacy, and support for health care, employee benefits, insurance and financial, technology and other services, manufacturing, construction, government and other performance and compliance sensitive organizations and their leaders.

Cynthia helps organizations and leaders understand and use the law and processes to design, implement, administer, enforce and defend pragmatic, legally defensible policies, regulations and laws, practices, internal and external controls, insurance and risk management, and other tools to manage people, workforce and operational performance, regulatory and operational compliance, confidential information and other legal and operational requirements in crisis, change and other times on an ongoing and special project basis.

Card image cap

Carolina M. Wirth

Of Counsel
Arnall Golden Gretory LLP

Carolina is of counsel in the firm’s Food & Drug practice and is a member of the Dietary Supplements and Pharmaceuticals & Biologics industry teams. She provides clients with FDA regulatory guidance related to food, dietary supplements, drugs, cosmetics, and medical device products.

Carolina’s prior experience as regulatory counsel in CDER’s Office of Regulatory Policy at the FDA and as an in-house lawyer at a biotechnology company has aided her work with domestic and international clients on regulatory issues associated with the marketing, labeling, packaging, and advertising of conventional foods, prescription and over-the- counter (OTC) drugs, cosmetics, and dietary supplements. She also assists clients with Federal Trade Commission (FTC) and Better Business Bureau National Advertising Division inquiries. In addition, Carolina counsels clients on the clinical trial issues, including reviewing informed consent documents and master clinical trial agreements.

Prior to joining AGG, Carolina served as a food and drug regulatory attorney in private practice, including at Am Law 100 and 200 ?rms. She also served as Senior Vice President for Regulatory Affairs at a veterinary regenerative medicine company, where she was responsible for its overall strategy for obtaining FDA approval of veterinary stem cell products for various species and indications.


Card image cap

Similar Courses

Card image cap
60 minutes
Alternative Energy & Renewables
This session’s panelists, all of whom have experience in the renewable energy and power sectors, will discuss valuation and other relevant issues in the context of expanding alternative and renewable energy sources, and the pressures this expansion will have on the merchant power sector.

American Bankruptcy Institute

$75

Add to Cart
Card image cap
60 minutes
An Administration Update on the New Regulatory and Enforcement Landscape
With the ushering in of a new administration, companies and their counsel will need to update their compliance measures to reflect the changing enforcement priorities of regulatory agencies, state Attorney Generals, and the DOJ. Hear from industry leaders to help you prepare for the upcoming changes and provide a road map for stress-free compliance.

Women, Influence & Power in Law Conference

$65

Add to Cart
Card image cap
64 minutes
Antitrust Under the Biden Administration: Have the Rules Changed?
As we are just approaching 18 months into the new administration, join our expert panelists as they highlight the various shifts and changes to antitrust policies and enforcement under President Joe Biden. Additionally this session will look into the anticipated increased regulatory and enforcement activity, as well as providing insight into the future within this space.

General Counsel Conference

$65

Add to Cart
Card image cap
61 minutes
ARMA’s Information Governance Implementation Model: The Way Forward For Information Governance
Learn about ARMA’s new model for Information Governance, the ARMA Information Governance Implementation Model (IGIM). In this session you’ll get an overview of this new methodology for helping your organization move forward in your Information Governance endeavors. You’ll also learn how this model can also be utilized for maturity assessment and how ARMA is connecting the IGIM to future resources.

Legalweek

$65

Add to Cart
Previous Next